Inventor · disambiguated record
R. Blake Pepinsky
Also filed as: PEPINSKY R B · PEPINSKY R BLAKE
51 granted patents·36 pending applications·2,429 citations·filing 1985–2023
99Inventor score
Top patents by PatentIndex Score
87 records- 0198US5747641ATat-derived transport polypeptide conjugatesBIOGEN INC·Filed 1995·Granted May 5, 1998·319 cites·5 claims
- 0298US5674980AFusion protein comprising tat-derived transport moietyBIOGEN INC·Filed 1995·Granted Oct 7, 1997·349 cites·10 claims
- 0397US8425910B2Composition comprising antibodies to LINGO or fragments thereofMI SHA·Filed 2011·Granted Apr 23, 2013·44 cites·11 claims
- 0497US8058406B2Composition comprising antibodies to LINGO or fragments thereofMI SHA·Filed 2009·Granted Nov 15, 2011·48 cites·15 claims
- 0597US5804604ATat-derived transport polypeptides and fusion proteinsBIOGEN INC·Filed 1995·Granted Sep 8, 1998·470 cites·14 claims
- 0697US5652122ANucleic acids encoding and methods of making tat-derived transport polypeptidesFiled 1995·Granted Jul 29, 1997·286 cites·9 claims
- 0796US8128926B2Sp35 antibodies and uses thereofMI SHA·Filed 2009·Granted Mar 6, 2012·29 cites·20 claims
- 0896US5670617ANucleic acid conjugates of tat-derived transport polypeptidesBIOGEN INC·Filed 1995·Granted Sep 23, 1997·189 cites·4 claims
- 0995US9066984B2Sp35 antibodies and uses thereofBIOGEN IDEC INC·Filed 2013·Granted Jun 30, 2015·26 cites·6 claims
- 1095US8551476B2SP35 antibodies and uses thereofMI SHA·Filed 2007·Granted Oct 8, 2013·34 cites·16 claims
- 1194US6316003B1Tat-derived transport polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1994·Granted Nov 13, 2001·174 cites·11 claims
- 1293US8153580B2Nogo receptor binding proteinMI SHA·Filed 2010·Granted Apr 10, 2012·17 cites·16 claims
- 1393US7465705B2Nogo receptor antagonistsUNIV YALE·Filed 2005·Granted Dec 16, 2008·37 cites·12 claims
- 1492US7442370B2Polymer conjugates of mutated neublastinBIOGEN IDEC INC·Filed 2003·Granted Oct 28, 2008·35 cites·68 claims
- 1592US5545723AMuteins of IFN-βBIOGEN INC·Filed 1994·Granted Aug 13, 1996·60 cites·15 claims
- 1690US8894999B2Use of DR6 and p75 antagonists to promote survival of cells of the nervous systemBIOGEN IDEC INC·Filed 2013·Granted Nov 25, 2014·10 cites·14 claims
- 1790US8609407B2Sp35 antibodies and uses thereofMI SHA·Filed 2012·Granted Dec 17, 2013·6 cites·18 claims
- 1887US11827702B2Anti-transferrin receptor antibodies and uses thereofBIOGEN MA INC·Filed 2022·Granted Nov 28, 2023·1 cites·11 claims
- 1987US8669345B2Nogo receptor antagonistsLEE DANIEL H S·Filed 2007·Granted Mar 11, 2014·16 cites·3 claims
- 2087US8501178B2Use of DR6 and p75 antagonists to promote survival of cells of the nervous systemMI SHA·Filed 2009·Granted Aug 6, 2013·7 cites·18 claims
- 2187US6897297B1Hydrophobically-modified protein compositions and methodsBIOGEN IDEC INC·Filed 2000·Granted May 24, 2005·21 cites·51 claims
- 2286US8765662B2NOGO receptor binding proteinMI SHA·Filed 2012·Granted Jul 1, 2014·6 cites·16 claims
- 2386US8486893B2Treatment of conditions involving demyelinationMI SHA·Filed 2005·Granted Jul 16, 2013·8 cites·20 claims
- 2485US8119114B2Polymer conjugates of mutated neublastinSAH DINAH WEN-YEE·Filed 2008·Granted Feb 21, 2012·3 cites·60 claims
- 2585US7785829B2Nogo receptor binding proteinBIOGEN IDEC INC·Filed 2004·Granted Aug 31, 2010·15 cites·29 claims
- 2684US8410061B2Functional antagonists of hedgehog activityWILLIAMS KEVIN·Filed 2002·Granted Apr 2, 2013·11 cites·41 claims
- 2783US9005926B2Methods of preventing and removing trisulfide bondsEVANS DAVID·Filed 2010·Granted Apr 14, 2015·5 cites·20 claims
- 2882US4879224ADNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptidesBIOGEN INC·Filed 1985·Granted Nov 7, 1989·44 cites·9 claims
- 2981US8932821B2NOGO receptor binding proteinBIOGEN IDEC INC·Filed 2013·Granted Jan 13, 2015·3 cites·4 claims
- 3081US8722862B2Refolding transforming growth factor beta family proteinsROSSOMANDO ANTHONY·Filed 2005·Granted May 13, 2014·3 cites·28 claims
- 3178US8263553B2Neublastin variantsROSSOMANDO ANTHONY·Filed 2005·Granted Sep 11, 2012·3 cites·219 claims
- 3278US7196112B2Cell adhesion inhibitorsBIOGEN IDEC INC·Filed 2004·Granted Mar 27, 2007·4 cites·87 claims
- 3376US9745375B2Compositions comprising antibodies to LINGO or fragments thereofBIOGEN MA INC·Filed 2016·Granted Aug 29, 2017·1 cites·21 claims
- 3476US9228015B2Nogo receptor antagonists and methods of increasing neurite outgrowthBIOGEN IDEC INC·Filed 2014·Granted Jan 5, 2016·2 cites·5 claims
- 3576US8030456B2Nogo receptor antagonistsUNIV YALE·Filed 2008·Granted Oct 4, 2011·2 cites·2 claims
- 3675US8642732B2Polymer-conjugated glycosylated neublastinSAH DINAH WEN-YEE·Filed 2012·Granted Feb 4, 2014·2 cites·22 claims
- 3775US2021395360A1SP35 Antibodies And Uses ThereofBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 3874US6127332AMuteins of IFN-βBIOGEN INC·Filed 1997·Granted Oct 3, 2000·27 cites·8 claims
- 3973US9796780B2LINGO-2 antagonists for treatment of conditions involving motor neuronsBIOGEN MA INC·Filed 2013·Granted Oct 24, 2017·1 cites·9 claims
- 4071US9068992B2Screening methods for identifying Sp35 antagonistsBIOGEN IDEC INC·Filed 2013·Granted Jun 30, 2015·1 cites·20 claims
- 4171US2020317775A1SP35 Antibodies And Uses ThereofBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 4269US5484711ADNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VIBIOGEN INC·Filed 1993·Granted Jan 16, 1996·18 cites·8 claims
- 4369US2024158494A1Anti-transferrin receptor antibodies and uses thereofBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 4469US2020297800A1Use of lingo-4 antagonists in the treatment of conditions involving demyelinationBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 4568US10308706B2Methods of preventing and removing trisulfide bondsBIOGEN MA INC·Filed 2015·Granted Jun 4, 2019·1 cites·16 claims
- 4668US2009054632A1Hydrophobically-modified protein compositions and methodsBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 4767US8163875B2Polymer conjugated glycosylated neublastinSAH DINAH WEN-YEE·Filed 2004·Granted Apr 24, 2012·2 cites·48 claims
- 4867US5359033ACleaved dimers of mullerian inhibiting substance-like polypeptidesBIOGEN INC·Filed 1989·Granted Oct 25, 1994·12 cites·5 claims
- 4967US2019161546A1SP35 Antibodies And Uses ThereofBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 5066US8017733B2Polyalkylene polymer compounds and uses thereofBIOGEN IDEC INC·Filed 2004·Granted Sep 13, 2011·4 cites·6 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →